Biotech company developing thymus-targeted bifunctional antibody therapies to restore immune tolerance and treat autoimmune diseases, starting with Type 1 diabetes.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.